Eva Forssell-Aronsson

15PUBLICATIONS
27CO-AUTHORS
Pharmaceutical delivery technologiesRadiation therapyAcceleratorsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Instruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 18, 2026
Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapy.

|Aug 28, 2025
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide.

Nishte Rassol, Charlotte Ytterbrink, Daniella Pettersson

|Aug 28, 2025
Short and long-term effects on the thyroid proteome after 131I exposure.

Klara Insulander Björk, Britta Langen, Anja Schroff

|Aug 28, 2025
Early proteomic response in thyroid gland after 131I administration in female Balb/c mice.

Nils Rudqvist, Johan Spetz, Emil Schüler

|Aug 12, 2025
Late apoptotic effects after treatment with 177Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model.

Mikael Elvborn, Nishte Rassol, Daniella Pettersson

|Sep 24, 2024
Usefulness and limitations of various detector systems for estimation of131I thyroid activity following an RN event.

Martin Hjellström, Frida Westerbergh, Eva Forssell-Aronsson

Pageof 3

Frequent Collaborators

3 joint publications

Johan Spetz

3 joint publications

Magnus Gram

2 joint publications

Nishte Rassol

2 joint publications

Toshima Z Parris